From L-R: COO David Shoultz, CEO Daniel-Adriano Silva and CSO Alfredo Quijano Rubio (Monod Bio)
David Baker lab spinout scores seed funding to build a biosensor from engineered protein
After embarking on the journey of co-founding a biotech, Daniel-Adriano Silva was in search of his next mission. He visited David Baker’s laboratory at the University of Washington’s Institute for Protein Design, where he had done his post-doctorate research. There, he reconnected with Alfredo Quijano Rubio, who had just finished his PhD and built a novel biosensor technology. The technology caught Silva’s attention.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.
